2931 logo

Euglena Co., Ltd. Stock Price

TSE:2931 Community·JP¥50.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

2931 Share Price Performance

JP¥362.00
-83.00 (-18.65%)
JP¥362.00
-83.00 (-18.65%)
Price JP¥362.00

2931 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and good value.

0 Risks
3 Rewards

Euglena Co., Ltd. Key Details

JP¥51.6b

Revenue

JP¥15.9b

Cost of Revenue

JP¥35.7b

Gross Profit

JP¥36.0b

Other Expenses

-JP¥330.0m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-2.37
69.13%
-0.64%
82.5%
View Full Analysis

About 2931

Founded
2005
Employees
793
CEO
Tomohiro Wakahara
WebsiteView website
www.euglena.jp

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It operates through there segments: Healthcare Business; Biofuel Business; and Other businesses. The company manufactures and sells health foods and cosmetics utilizing microalgae, such as euglena and chlorella. In addition, the company develops biofuel technology and environmental related technology for microalgae and industrial waste oil; development and research in agriculture business comprising feed and fertilizer, bioinformatics, and social businesses; and invests in biotechnology related businesses. Further, the company provides genome analysis services. Euglena Co., Ltd. was incorporated in 2005 and is headquartered in Tokyo, Japan.

Recent 2931 News & Updates

Recent updates

No updates